EUVIMEDEUVIMED entdecken
Crossref

Trifluoromethyl Rhodium‐Carbynoid in [2+1+2] Cycloadditions

Wen-Wen Zhao, Meng-Yang Tian, Yi-Lin Zhou, Lu-Jie Liu, Shao-Fang Tian, Chun-Yang He, Xing-Zhi Yang, Yong-Zheng Chen, Wen-Yong Han iD

Angewandte Chemie International Edition · 22.03.2024 · 63 (13)

DOI: 10.1002/anie.202318887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 23.02.2024. Verfasst von Wen-Wen Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biocatalysis & Chiral Drug Synthesis of Guizhou Province, School of Pharmacy, Zunyi Medical University, No. 6 West Xuefu Rd., 56300…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Research Project of Guizhou Province, Guizhou Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trifluoromethyl cationic carbyne (CF 3 C + :) possessing dual carbene‐carbocation behavior emulated as trifluoromethyl metal‐carbynoid (CF 3 C + =M) has not been explored yet, and its reaction characteristics are unknown. Herein, a novel α‐diazotrifluoroethyl sulfonium salt was prepared and used in Rh‐catalyzed three‐component [2+1+2] cycloadditions for the first time with commercially available N ‐fused heteroarenes and nitriles, yielding a series of imidazo[1,5‐ a ] N ‐heterocycles that are of interest in medicinal chemistry, in which the insertion of trifluoromethyl Rh‐carbynoid (CF 3 C + =Rh) into C=N bonds of N ‐fused heteroarenes was involved. This strategy demonstrates synthetic applications in late‐stage modification of pharmaceuticals, construction of CD 3 ‐containing N ‐heterocycles, gram‐scale experiments, and synthesis of phosphodiesterase 10A inhibitor analog. These highly valuable and modifiable imidazo[1,5‐ a ] N ‐heterocycles exhibit good antitumor activity in vitro, thus demonstrating their potential applications in medicinal chemistry.

Schlagwörter

Stichwörter der Autor:innen

CycloadditionsN-heteroarenesTrifluorodiazoethaneTrifluoromethyl Rh-carbynoid

Autor:innen und Institutionen

  • Key Laboratory of Biocatalysis & Chiral Drug Synthesis of Guizhou Province, School of Pharmacy, Zunyi Medical University, No. 6 West Xuefu Rd., 563006, Zunyi, China.
  • Key Laboratory of Basic Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, No. 6 West Xuefu Rd., 563006, Zunyi, China.
  • State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, 132 Lanhei Road, 650201, Kunming, China.

ORCID-Profile: Wen-Yong Han

Förderung

  • National Natural Science Foundation of China
  • Natural Science Research Project of Guizhou Province
  • Guizhou Provincial Science and Technology Department
  • Zunyi Medical University
  • Science and Technology Department of Zunyi
  • Fifth Batch of Talent Base in Guizhou Province

Zitieren

APA

Zhao, W. W., Tian, M. Y., Zhou, Y. L., Liu, L. J., Tian, S. F., He, C. Y., Yang, X. Z., Chen, Y. Z., & Han, W. Y. (2024). Trifluoromethyl Rhodium‐Carbynoid in [2+1+2] Cycloadditions. Angewandte Chemie International Edition, 63(13). https://doi.org/10.1002/anie.202318887

Vancouver

Zhao WW, Tian MY, Zhou YL, Liu LJ, Tian SF, He CY, et al. Trifluoromethyl Rhodium‐Carbynoid in [2+1+2] Cycloadditions. Angewandte Chemie International Edition. 2024;63(13). doi:10.1002/anie.202318887

BibTeX
@article{Zhao2024,
  author = {Zhao, Wen-Wen and Tian, Meng-Yang and Zhou, Yi-Lin and Liu, Lu-Jie and Tian, Shao-Fang and He, Chun-Yang and Yang, Xing-Zhi and Chen, Yong-Zheng and Han, Wen-Yong},
  title = {Trifluoromethyl Rhodium‐Carbynoid in [2+1+2] Cycloadditions},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {13},
  doi = {10.1002/anie.202318887}
}
Kostenlos starten →